The correct medical name for bronchitis pneumonia is bronchopneumonia, and what anti-inflammatory medication a patient with bronchopneumonia needs to take should be determined by the causative agent causing the bronchopneumonia. If the bronchopneumonia is caused by a viral infection, it can be treated with drugs such as busulfan anti-inflammatory tablets and ribavirin. If the bronchopneumonia is caused by pathogenic infections such as chlamydia and bacteria, it can be treated with erythromycin, levofloxacin, etc. If the bronchopneumonia is caused by fungal infection, it can be treated with voriconazole, and it is recommended to follow the doctor’s prescription for medication. If the bronchopneumonia is caused by viral infection, due to the inaccurate efficacy of various antiviral drugs, you can usually choose Chinese medicine to clear heat and detoxify the toxin, such as Pudilan anti-inflammatory tablets, Qingkailing granules, combined with cough and phlegm, antispasmodic and asthma drugs for symptomatic treatment, such as Aminophylline, Ambroxol hydrochloride tablets, and also use antiviral drugs such as Ribavirin for treatment. Second, bacterial infection medication: 1. If bronchopneumonia is caused by pathogens such as Chlamydia, Mycoplasma, and Catamorax, you can choose macrolide antibiotics such as erythromycin, roxithromycin, clarithromycin, azithromycin, etc. Patients over 18 years old can directly choose quinolones, such as levofloxacin, moxifloxacin hydrochloride, etc. Patients with more severe disease or high-risk groups can directly choose moxifloxacin hydrochloride; 2. If bronchopneumonia is caused by Streptococcus pneumoniae infection, you can directly choose cephalosporins such as cefixime and also amoxicillin treatment; 3. If bronchopneumonia is caused by methicillin-resistant Staphylococcus aureus infection, at this time, oral anti-inflammatory drugs have no obvious effect and should be used intravenously with vancomycin hydrochloride, If the bronchopneumonia is caused by gram-negative bacillus infection, oral medication is also not recommended and intravenous antibiotics such as meropenem, imipenem cilastatin sodium, etc. should be used. Third, fungal infection medication: If bronchopneumonia patients combined with fungal infections, such as Candida albicans, Aspergillus, etc., voriconazole can be preferred, patients with severe disease can choose intravenous medication, patients with slightly milder disease can choose oral medication. Patients with bronchopneumonia need to choose appropriate anti-inflammatory drugs according to the causative organisms that cause bronchopneumonia, and can empirically take a variety of antibiotics and combine them if necessary, especially if a mixed infection is considered. However, it is not recommended that patients purchase their own medications and use them to avoid adverse drug reactions from improper use and possible delays.